Linezolid Injection, Solution
Product Images NDC 0781-3433

This is a medication called Linezolid Injection contained in a single-dose container. It is sterile and nonpyrogenic, and is for intravenous use only. The container contains 200mg/100mL of Linezolid Injection. The medication also contains Dextrose, Sodium Citrate, Citric Acid, and Water for Injection. The pH of this medication is adjusted to 4.8 with sodium hydroxide or hydrochloric acid. It is recommended to check for leaks before administering the medication. It is also important to keep the medication out of the reach of children and protect it from light. This medication is manufactured in Switzerland by ACS Dobfar Info S.A. for Sandoz Inc., Princeton, NJ. The usual dosage should be obtained from the package insert. Batch N° and expiration date are also indicated.*

This is a description of a medication called Linezolid Injection. It's used for intravenous use only and comes in a 600mg/300mL single-dose container that is sterile and nonpyrogenic. Each mL contains Linezolid 2mg, Dextrose USP 50.24mg, Sodium Citrate USP 1.64mg, Citric Acid USP 0.85mg, and Water for Injection USP. It should not be used in series connections, and leaks should be checked for prior to administration. The usual dosage is included in the package insert. It should be stored between 20-25C and protected from light; the overwrap should be retained prior to use. This medication is manufactured in Switzerland for Sandoz Inc. in Princeton, NJ, and is a product of India.*

This is a graph displaying the plasma concentration of Linezolid in pg/mL over time (in hours) after taking a 600mg oral dose every 12 hours. The graph only displays up to 12 hours after the dose.*